Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

MLA

M. Buti, et al. “Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort.” Journal of Hepatology, vol. 64, Jan. 2016, pp. S217–18. EBSCOhost, https://doi.org/10.1016/s0168-8278(16)00188-4.

APA

M. Buti, J. de la Vega, Christie Perelló, Rosa Maria Morillas, Javier Crespo, P.S. Pobre, Lucia Bonet, Javier Ampuero, Gloria Sánchez-Antolín, J.R. Fernandez, Jose Ramon Salcines, M.A. Simón, Juan Turnes, Carlos López, Oreste Lo Iacono, Miguel Fernández Bermejo, I. Fenandez, Susana Llerena, J.M. Moreno, … J.J. Sanchez-Ruano. (2016). Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort. Journal of Hepatology, 64, S217–S218. https://doi.org/10.1016/s0168-8278(16)00188-4

Chicago

M. Buti, J. de la Vega, Christie Perelló, Rosa Maria Morillas, Javier Crespo, P.S. Pobre, Lucia Bonet, et al. 2016. “Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort.” Journal of Hepatology 64 (January): S217–18. doi:10.1016/s0168-8278(16)00188-4.